1. Home
  2. TPCS vs PDSB Comparison

TPCS vs PDSB Comparison

Compare TPCS & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • PDSB
  • Stock Information
  • Founded
  • TPCS 1956
  • PDSB 2005
  • Country
  • TPCS United States
  • PDSB United States
  • Employees
  • TPCS N/A
  • PDSB N/A
  • Industry
  • TPCS Metal Fabrications
  • PDSB Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPCS Industrials
  • PDSB Health Care
  • Exchange
  • TPCS Nasdaq
  • PDSB Nasdaq
  • Market Cap
  • TPCS 51.4M
  • PDSB 54.5M
  • IPO Year
  • TPCS N/A
  • PDSB N/A
  • Fundamental
  • Price
  • TPCS $5.36
  • PDSB $1.17
  • Analyst Decision
  • TPCS
  • PDSB Strong Buy
  • Analyst Count
  • TPCS 0
  • PDSB 2
  • Target Price
  • TPCS N/A
  • PDSB $10.00
  • AVG Volume (30 Days)
  • TPCS 60.2K
  • PDSB 552.0K
  • Earning Date
  • TPCS 08-21-2025
  • PDSB 11-13-2025
  • Dividend Yield
  • TPCS N/A
  • PDSB N/A
  • EPS Growth
  • TPCS N/A
  • PDSB N/A
  • EPS
  • TPCS N/A
  • PDSB N/A
  • Revenue
  • TPCS $33,424,000.00
  • PDSB N/A
  • Revenue This Year
  • TPCS N/A
  • PDSB N/A
  • Revenue Next Year
  • TPCS N/A
  • PDSB N/A
  • P/E Ratio
  • TPCS N/A
  • PDSB N/A
  • Revenue Growth
  • TPCS 3.78
  • PDSB N/A
  • 52 Week Low
  • TPCS $2.05
  • PDSB $0.85
  • 52 Week High
  • TPCS $6.25
  • PDSB $4.29
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 53.99
  • PDSB 46.75
  • Support Level
  • TPCS $5.10
  • PDSB $1.12
  • Resistance Level
  • TPCS $5.50
  • PDSB $1.21
  • Average True Range (ATR)
  • TPCS 0.23
  • PDSB 0.08
  • MACD
  • TPCS -0.33
  • PDSB -0.01
  • Stochastic Oscillator
  • TPCS 93.21
  • PDSB 28.95

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: